We are on a mission to improve patient outcomes
We create novel medicines that benefit patients in need
About ResoTher Pharma
We target neutrophil driven inflamation and act as resolution therapy
ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on discovering and developing peptide-based drugs as resolution therapy for diseases where inflammation plays a key pathological role.
ResoTher Pharma appoints Anders Kronborg as Chief Executive Officer
Resother Pharma A/S (“ResoTher”) today announced the appointment of Anders [...]
ResoTher Pharma appoints Dr. Markus Weissbach as Chief Medical Officer
ResoTher Pharma is pleased to announce the appointment of Dr. [...]
Resother Pharma initiates First in Human studies with RTP-026
ResoTher Pharma today announced that the company has received approval [...]
Latest News
ResoTher Pharma appoints Anders Kronborg as Chief Executive Officer
Resother Pharma A/S (“ResoTher”) today announced the appointment of Anders [...]
ResoTher Pharma appoints Dr. Markus Weissbach as Chief Medical Officer
ResoTher Pharma is pleased to announce the appointment of Dr. [...]
Resother Pharma initiates First in Human studies with RTP-026
ResoTher Pharma today announced that the company has received approval [...]
